|
Volumn 32, Issue SUPPL.82, 2014, Pages
|
Tocilizumab, an effective treatment for relapsing giant cell arteritis
|
Author keywords
Giant cell arteritis; Interleukin 6; Tocilizumab
|
Indexed keywords
C REACTIVE PROTEIN;
CORTICOSTEROID;
FOLIC ACID;
HYDROXYCHLOROQUINE SULFATE;
METHOTREXATE;
METHYLPREDNISOLONE;
PREDNISONE;
TOCILIZUMAB;
AGED;
ANXIETY DISORDER;
ARTICLE;
BLEEDING;
BODY WEIGHT DISORDER;
CASE REPORT;
CLINICAL ASSESSMENT;
CUSHINGOID SYNDROME;
DEPRESSION;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
ERYTHROCYTE SEDIMENTATION RATE;
FACE EDEMA;
FATIGUE;
FEMALE;
GIANT CELL ARTERITIS;
HUMAN;
INSOMNIA;
LABORATORY TEST;
MAGNETIC RESONANCE ANGIOGRAPHY;
MUSCLE ATROPHY;
PRIORITY JOURNAL;
RELAPSE;
RHEUMATIC POLYMYALGIA;
SKIN BRUISING;
TREATMENT DURATION;
TREATMENT RESPONSE;
WEIGHT GAIN;
AGED;
ANTIBODIES, MONOCLONAL, HUMANIZED;
BIOLOGICAL MARKERS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG MONITORING;
FEMALE;
GIANT CELL ARTERITIS;
GLUCOCORTICOIDS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTERLEUKIN-6;
MEDICATION THERAPY MANAGEMENT;
MONITORING, IMMUNOLOGIC;
RECURRENCE;
TREATMENT OUTCOME;
|
EID: 84901947482
PISSN: 0392856X
EISSN: 1593098X
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (26)
|
References (6)
|